BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15717766)

  • 1. Detection of growth hormone-releasing hormone in cytologic specimens of primary breast carcinoma.
    Chatzistamou I; Kondi-Pafiti A; Politi E; Koutselini H; Schally AV
    Acta Cytol; 2005; 49(1):108-9. PubMed ID: 15717766
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticotropin-releasing hormone, luteinizing hormone-releasing hormone, growth hormone-releasing hormone, and somatostatin-like immunoreactivities in biopsies from breast cancer patients.
    Ciocca DR; Puy LA; Fasoli LC; Tello O; Aznar JC; Gago FE; Papa SI; Sonego R
    Breast Cancer Res Treat; 1990 May; 15(3):175-84. PubMed ID: 1973621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate Receptor Alpha Immunohistochemistry in Cytology Specimens of Metastatic Breast Carcinoma.
    Sheikh UN; Cohen C; Siddiqui MT
    Acta Cytol; 2015; 59(4):298-304. PubMed ID: 26413911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G
    Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of immunocytochemistry in fine needle aspiration cytology diagnosis of mammary lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):738-43. PubMed ID: 17374259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration cytology of apocrine carcinoma of the breast. Review of cases in a three-year period.
    Ng WK
    Acta Cytol; 2002; 46(3):507-12. PubMed ID: 12040645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-needle aspiration of breast biopsy specimens: correlation of histologic and cytologic findings.
    Teixidor HS; Wojtasek DA; Reiches EM; Santos-Buch CA; Minick CR
    Radiology; 1992 Jul; 184(1):55-8. PubMed ID: 1319077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical detection of growth hormone-releasing factor (GRF) in neuroendocrine tumors].
    Gottschalk J; Rohde W
    Acta Histochem Suppl; 1988; 35():207-12. PubMed ID: 2843943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers.
    Kahán Z; Arencibia JM; Csernus VJ; Groot K; Kineman RD; Robinson WR; Schally AV
    J Clin Endocrinol Metab; 1999 Feb; 84(2):582-9. PubMed ID: 10022420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoepithelial cells in invasive breast carcinoma: a word of caution.
    Salman WD; Howat AJ
    J Clin Pathol; 2011 Jul; 64(7):644-5. PubMed ID: 21565859
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
    Fiel MI; Cernaianu G; Burstein DE; Batheja N
    Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone receptor is expressed in human breast cancer.
    Gebre-Medhin M; Kindblom LG; Wennbo H; Törnell J; Meis-Kindblom JM
    Am J Pathol; 2001 Apr; 158(4):1217-22. PubMed ID: 11290538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytology of argyrophilic carcinoma of the breast.
    Ravinsky E; Cavers DJ
    Acta Cytol; 1985; 29(1):1-6. PubMed ID: 3855579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar variant of infiltrating lobular carcinoma of the breast with stromal osteoclast-like giant cells.
    Pettinato G; Manivel JC; Picone A; Petrella G; Insabato L
    Pathol Res Pract; 1989 Sep; 185(3):388-94; discussion 394-6. PubMed ID: 2813192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytologic diagnosis of mammary tumors from aspiration biopsy smears. Comparison of cytologic and histologic findings in 2,III lesions and diagnostic use of cytophotometry.
    Zajicek J; Caspersson T; Jakobsson P; Kudynowski J; Linsk J; Us-Kraŝovec M
    Acta Cytol; 1970; 14(7):370-6. PubMed ID: 5280253
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytologic diagnosis of breast angiosarcoma].
    Parsi B; Dilhuydy MH; Léger F; Trojani M; de Mascarel I; Coindre JM; Bui NB; Marée D
    Arch Anat Cytol Pathol; 1989; 37(5-6):231-4. PubMed ID: 2604441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of cytologic grading in aspiration biopsy of breast carcinoma].
    Guo ZQ; Kan X; Deng WF
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):465-7, 509. PubMed ID: 4092541
    [No Abstract]   [Full Text] [Related]  

  • 18. Intratumoral heterogeneity of immunohistochemical marker expression in breast carcinoma: a tissue microarray-based study.
    Nassar A; Radhakrishnan A; Cabrero IA; Cotsonis GA; Cohen C
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):433-41. PubMed ID: 20485156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytologic diagnosis of mammary carcinoma from aspiration biopsy smears (report) (author's transl)].
    Zajicek J
    Verh Dtsch Ges Pathol; 1973; 57():165-8. PubMed ID: 4142168
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression.
    Shet T; Valsangar S; Dhende S
    Breast J; 2013; 19(2):222-4. PubMed ID: 23305535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.